Alkermes
Alkermes is a provider of innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies its scientific expertise, proprietary technologies, and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.
Financial Data
-
31st Dec 20 Source: CRO
- €557.6 million turnover
-
-€100.2 million
profit - 363 employees
-
31st Dec 19 Source: CRO
- €645.4 million turnover
-
-€138.8 million
profit - 361 employees
- 8 more years available »
Ranking
By Turnover
(€557.6 million)- 155th in Top Companies
- 21st in Health
- 19th in Pharma
By Employees
(363)- 443rd in Top Companies
- 67th in Health
- 42nd in Pharma
-
- 363
- €557.6 million
Employees
- Richard Pops CEO/Managing Director
Latest News
- 2:02am Nama clashes with Fingal council over lands with space for up to 7,000 new homes
- May 20 Attempt by investors to appoint inspector to firm ‘without precedent’, court hears
- May 20 Amarenco and SSE among groups to win green Eirgrid contracts
- May 20 Cerberus collected €113m last year from Irish loans it bought after the 2008 crash
- May 20 European shares finish difficult week with a gain